Processa Pharmaceuticals (PCSA) CAO buys 2,118 shares at $2.22 in open market

Rhea-AI Filing Summary

Processa Pharmaceuticals, Inc. Chief Administrative Officer Wendy Guy reported an open-market purchase of 2,118 shares of common stock at $2.22 per share on June 15, 2026. After this transaction, Guy directly holds 11,958 common shares and has an additional 333 shares reported as indirectly owned through CorLyst, LLC.

Insider Trade Summary

Net Buyer: 2,118 shares ($4,702)

Net Buy 2 txns

Insider Guy Wendy

Role Chief Administrative Officer

Bought 2,118 shs ($5K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	2,118	$2.22	$5K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 11,958 shares (Direct, null); Common Stock — 333 shares (Indirect, By CorLyst, LLC)

Footnotes (1)

Key Figures

Open-market purchase: 2,118 shares Purchase price: $2.22 per share Direct holdings after transaction: 11,958 shares +2 more

5 metrics

Open-market purchase 2,118 shares Common Stock bought on June 15, 2026

Purchase price $2.22 per share Price for 2,118 common shares bought

Direct holdings after transaction 11,958 shares Common Stock directly owned following purchase

Indirect holdings 333 shares Common Stock held indirectly through CorLyst, LLC

Net common shares bought 2,118 shares Net buy per transaction summary

Key Terms

open-market purchase, indirect ownership, Common Stock, Form 4

4 terms

open-market purchase financial

"transaction_action is listed as "open-market purchase" for 2,118 shares"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

"333 common shares are reported with indirect ownership "By CorLyst, LLC""

Common Stock financial

"Both transactions involve the issuer's Common Stock security title"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"Insider trading activity is disclosed through this Form 4 filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Guy Wendy

(Last) (First) (Middle)

C/O PROCESSA PHARMACEUTICALS, INC.

601 21ST STREET SUITE 300

(Street)

VERO BEACH FLORIDA 32960

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Processa Pharmaceuticals, Inc. [ PCSA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Administrative Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/15/2026		P		2,118	A	$2.22	11,958	D
Common Stock								333	I	By CorLyst, LLC

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Wendy Guy by John J. Wolfel, as Attorney-in-Fact	06/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Processa Pharmaceuticals (PCSA) report for Wendy Guy?

Wendy Guy reported buying 2,118 Processa shares in the open market. She purchased common stock at $2.22 per share and now directly holds 11,958 shares, plus 333 shares reported as indirectly owned through CorLyst, LLC.

At what price did Processa Pharmaceuticals (PCSA) insider Wendy Guy buy shares?

Wendy Guy bought Processa common stock at $2.22 per share. The Form 4 shows an open-market purchase of 2,118 shares on June 15, 2026, at this price, increasing her directly held position to 11,958 shares afterward.

How many Processa (PCSA) shares does Wendy Guy own after the latest Form 4?

After the reported transaction, Wendy Guy directly owns 11,958 shares. The filing also lists 333 additional shares as indirectly owned through CorLyst, LLC, reflecting both direct and indirect holdings of Processa common stock.

Was the Processa (PCSA) insider trade by Wendy Guy a purchase or sale?

The reported insider trade by Wendy Guy was an open-market purchase. According to the Form 4, she bought 2,118 shares of Processa common stock at $2.22 per share, with no sales reported in this filing.

What indirect holdings of Processa (PCSA) stock are reported for Wendy Guy?

The Form 4 shows 333 Processa shares as indirectly owned. These common shares are reported as held through CorLyst, LLC, separate from the 11,958 shares she holds directly after the June 15, 2026 purchase.